An official website of the United States government
Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Home > About CHTN

About CHTN

Our Story and Mission

The Cooperative Human Tissue Network (CHTN) is a pioneering research initiative funded by the National Cancer Institute (NCI) at the National Institutes of Health (NIH) and managed at the NCI's Cancer Diagnosis Program (CDP). Established in 1987, CHTN is dedicated to advancing basic and early translational cancer research by providing scientists with access to high-quality human biospecimens.

There are six divisions of CHTN, working collaboratively to ensure an equitable and fair distribution of biospecimens to researchers at a reasonable price.

CHTN's mission is to facilitate the acquisition of human tissue samples, supporting groundbreaking discoveries in cancer biology, diagnostics, and treatment development across academic institutions and industry, while maintaining the integrity of every sample entrusted to us.

CHTN Divisions

The CHTN is comprised of six divisions that work together as a network. There are five adult divisions and one pediatric division.

Learn More

CHTN Leadership

Each CHTN Division has a principal investigator who oversees operations. Click to learn more about our principal investigators, their background, and the work they do.

Learn More

Our Numbers

Review what the CHTN has accomplished since 1987 by exploring our data.

Learn More